ARA INVESTORS ALERT: Lieff Cabraser Announces Securities Class Action Against American Renal Associates Holdings, Inc.
By a
If you purchased or otherwise acquired ARA securities during the Class Period and/or pursuant or traceable to the IPO, you may move the Court for appointment as lead plaintiff by no later than
The actions allege that ARA filed a false and misleading Prospectus as part of its
On
On
On
For more information about Lieff Cabraser and the firm's representation of investors, please visit http://www.lieffcabraser.com.
This press release may be considered
Keywords for this news article include: Kidney,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2016, NewsRx LLC
Researchers from Duke University Report Recent Findings in Antibiotics (National Utilization and Forecasting of Ototopical Antibiotics: Medicaid Data…
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News